ANI Pharmaceuticals ANIP Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from ANI Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ANI Pharmaceuticals's free cash flow yield?
- ANI Pharmaceuticals (ANIP) reported free cash flow yield of 11.1% in Q1 2026.
- How has ANI Pharmaceuticals's free cash flow yield changed year-over-year?
- ANI Pharmaceuticals's free cash flow yield increased by 142.6% year-over-year, from 4.6% to 11.1%.
- What is the long-term trend for ANI Pharmaceuticals's free cash flow yield?
- Over 3 years (2022 to 2025), ANI Pharmaceuticals's free cash flow yield has grown at a 18.1% compound annual growth rate (CAGR), from -5.9% to 9.7%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.